Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
486427-17-2
is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin
female nude mice bearing HeyA8 tumors in the peritoneal cavity are randomly divided into 4 groups (n=10 per group): 1) vehicle orally twice daily and phosphate-buffered saline intraperitoneally weekly (control)
2-(HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS WNT SIGNALING MODULATORS
MK 2206 Size:Solid 10 mg 486427-17-2MK2206 is a Akt inhibitor, is also an orally bioavailable allosteric inhibitor of the serine threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor MK2206 binds to and inhibits the activity of Akt in a non ATP competitive manner, which may result in the inhibition of the PI3K Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Product information CAS Number: